Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Francesconi G et al. – The study suggests that 250 mg/day terbinafine is an effective and well–tolerated alternative to drug therapy of cutaneous sporotrichosis in a population in which itraconazole use is not possible.

   

Related Articles

Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Karnataka, India
International Journal of Dermatology, 10/30/09    Relevance Score: 87%

Oral potassium iodide for the treatment of sporotrichosis
Cochrane Reviews, 10/26/09    Relevance Score: 85%

Today in Clinical Pharmacology...keeping you current

Resorption and elimination kinetics of benzoic acid during chemical necrectomy in deep burns
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09

Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Haematologica, 12/18/09

Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/18/09

Today in Dermatology...keeping you current

Juvenile bullous pemphigoid: the presentation and follow-up of six cases
Journal of the European Academy of Dermatology and Venereology, 12/18/09

Is there any relation between serum insulin and insulin-like growth factor-I in non-diabetic patients with skin tag
Journal of the European Academy of Dermatology and Venereology, 12/18/09

Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas
Journal of the European Academy of Dermatology and Venereology, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address